Advertisement

The Cost of Parkinson’s Disease: A Systematic Review

  • Sávio Luís Oliveira da SilvaEmail author
  • Oswaldo Luiz Gonçalves Quelhas
  • Julio Vieira Neto
  • Marco Antônio Araújo Leite
Conference paper
Part of the Springer Proceedings in Business and Economics book series (SPBE)

Abstract

Determining the costs of a disease facilitates the understanding and evaluation of their impact with its main stakeholders. The aim of this literature review is to deepen the studies on the individual costs of Parkinson’s disease, reinforcing the understanding of its impacts on the healthcare system.

Keywords

Parkinson’s disease Costs Healthcare system 

References

  1. 1.
    Bovolenta, T.M., Silva, S.M.C.A., Saba, R.A., Borges, V., Ferraz, H.B., Felicio, A.C.: Average annual cost of Parkinson’s disease in São Paulo, Brazil, with a focus on disease-related motor symptoms. Clin. Interv. Aging 12, 2095–2108 (2017)Google Scholar
  2. 2.
    Bovolenta, TM., Silva, S.M.C.A., Saba, R.A., Borges, V., Ferraz, H,B., Felicio, A.C.: Systematic review and critical analysis of cost studies associated with Parkinson’s Disease. Hindawi Parkinson’s Disease, 1–11 (2017)Google Scholar
  3. 3.
    Brasil. Ministério da Saúde.: Avaliação econômica em saúde: desafios para gestão no Sistema Único de Saúde. Ministério da Saúde, Brasília (2008)Google Scholar
  4. 4.
    Cubo, E., Alvarez, E., Morant, C., Cuesta, J.P., Martín, P.M., Génova, R., Freire, J.M.: Burden of disease related to Parkinson’s Disease in Spain in the Year 2000. Mov. Disord. 20(11), 1481–1487 (2005)CrossRefGoogle Scholar
  5. 5.
    Daneault, J.F., Carignan, B., Sadikot, A.F., Panisset, M., Duval, C.: Drug-induced dyskinesia in Parkinson’s disease: should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia? BMC Med. 11(73), 1–18 (2013)Google Scholar
  6. 6.
    Findley, L.J.: The economic impact of Parkinson’s disease. Parkinsonism and Relat. Disord. 13, S8–S12 (2007)CrossRefGoogle Scholar
  7. 7.
    García-Ramos, R., Valdés, E.L., Ballesteros, L., Jesús, S., Mir, P.: The social impact of Parkinson’s disease in Spain: report by the Spanish foundation for the brain. Neurología 31(6), 401–413 (2016)CrossRefGoogle Scholar
  8. 8.
    Gaskin, J., Gomes, J., Darshan, S., Krewski, D.: Burden of neurological conditions in Canada. NeuroToxicology 61, 2–10 (2017)CrossRefGoogle Scholar
  9. 9.
    Gil-Prieto, R., Pascual-Garcia, R., San-Roman-Montero, J., Martínez-Martin, P., Castrodeza-Sanz, J., Gil-de-Miguel, A.: Measuring the burden of hospitalization in patients with Parkinson’s Disease in Spain. PLoS ONE 11(3), 1–11 (2016)CrossRefGoogle Scholar
  10. 10.
    Jaglal, S.B., Guilcher, S.J.T., Bereket, T., Kwan, M., Munce, S., Conklin, J., Versnel, J., Packer, T., Verrier, M., Marras, C., Pitzul, K.B., Riopelle, R.: Development of a Chronic Care Model for Neurological Conditions (CCM-NC). BMC Health Serv. Res. 14, 1–12 (2014)CrossRefGoogle Scholar
  11. 11.
    Johnson, S.J., Diener, M.D., Kaltenboeck, A., Birnbaum, H.G., Grubb, E., Siderowf, A.D.: An economic model of Parkinson’s disease: implications for slowing progression in the United States. Mov. Disord. 28(3), 319–326 (2013)Google Scholar
  12. 12.
    Johnson, S.J., Kaltenboeck, A., Diener, M.D., Birnbaum, H.G., Grubb, E., Castelli-Haley, J., Siderowf, A.D.: Costs of Parkinson’s disease in a privately insured population. PharmacoEconomics 31, 799–806 (2013)Google Scholar
  13. 13.
    Koay, L., Rose, J., Abdelhafiz, A.H.: Factors that lead to hospitalisation in patients with Parkinson disease—a systematic review. Int. J. Clin. Pract. 72, 1–5 (2018)CrossRefGoogle Scholar
  14. 14.
    Kowal, S.L., Dall, T.M., Chakrabarti, R., Storm, M.V., Jain, A.: The current and projected economic burden of Parkinson’s disease in the United States. Mov. Disord. 28(3), 311–318 (2013)CrossRefGoogle Scholar
  15. 15.
    Lindgren, P., von Campenhausen, S., Spottke, E., Siebert, U., Dodel, R.: Cost of Parkinson’s disease in Europe. Eur. J. Neurol. 12(Suppl. 1), 68–73 (2005)CrossRefGoogle Scholar
  16. 16.
    Martínez-Martin, P., Rodriguez-Blazquez, C., Paz, S., Forjaz, M.J., Frades-Payo, B., Cubo, E., Pedro-Cuesta, J., Lizán, L.: Parkinson symptoms and health related quality of life as predictors of costs: a longitudinal observational study with linear mixed model analysis. PLoS ONE 10(12), 1–16 (2015)CrossRefGoogle Scholar
  17. 17.
    Moraz, G., Garcez, A.S., Assis, E.M., Santos, J.P., Barcellos, N.T., Kroeff, L.R.: Estudos de cisto-efetividade em saúde no Brasil: uma revisão sistemática. Ciência & Saúde Coletiva 20(10), 3211–3229 (2015)Google Scholar
  18. 18.
    Mudiyanselage, S.B., Watts, J.J., Ochom, J.A., Lane, L., Murphy, A.T., Morris, M.E., Iansek, R.: Cost of living with Parkinson’s disease over 12 months in Australia: a prospective cohort study. Hindawi Parkinson’s Disease 1–14 (2017)Google Scholar
  19. 19.
    Oliveira, M.L., Santos, L.M.P., Silva, E.N.: Bases metodológicas para estudos de custos da doença no Brasil. Rev Nutr 27(5), 585–595 (2014)CrossRefGoogle Scholar
  20. 20.
    Pinto, M., Ugá, M.A.D.: O custo de doenças tabaco-relacionadas para o Sistema Único de Saúde. Cad Saúde Pública 26(6), 1234–1245 (2010)CrossRefGoogle Scholar
  21. 21.
    Richy, F.F., Pietri, G., Moran, K.A., Senior, E., Makaroff, L.E.: Compliance with pharmacotherapy and direct healthcare costs in patients with Parkinson’s disease: a retrospective claims database analysis. Appl. Health Econ. Health Policy 11, 395–406 (2013)CrossRefGoogle Scholar
  22. 22.
    Rodríguez-Blázquez, C., Forjaz, M.J., Lizán, L., Paz, S., Martínez-Martín, P.: Estimating the direct and indirect costs associated with Parkinson’s disease. Expert Rev. Pharmacoeconomics Outcomes Res 1–23 (2015)Google Scholar
  23. 23.
    Schlatter, R.P.: Estudo de custos em doenças crônicas não transmissíveis: manejo da cardiopatia isquêmica e diagnostic precoce de cancer hereditário. Doctoral Thesis. Federal University of Rio Grande do Sul, Brasil (2016)Google Scholar
  24. 24.
    Secoli, S.R., Nita, M.E., Ono-Nita, S.K., Nobre, M.: Avaliação de tecnologia em saúde. II. A análise de custo-efetivida-de. Arq Gastroenterol 47(4), 329–333 (2010)Google Scholar
  25. 25.
    Segel, J.E.: Cost-of-Illness studies: a primer. [s.l.]: RTI International. RTI-UNC Center of Excellence in Health Promotion Economics (2006)Google Scholar
  26. 26.
    Silva, E.N., Silva, M.T., Pereira, M.G.: Identificação, mensuração e valoração de custos em saúde. Epidemiol Serv Saúde 25(2), 437–439 (2016)Google Scholar
  27. 27.
    Tamás, G., Gulácsi, L., Bereczki, D., Baji, P., Takáts, A., Brodzky, V., Péntek, M.: Quality of life and costs in Parkinson’s disease: a cross sectional study in Hungary. PLoS ONE 9(9), 1–7 (2014)CrossRefGoogle Scholar
  28. 28.
    Vanni, T., Luz, P.M., Ribeiro, R.A., Novaes, H.M.D., Polanczyk, C.A.: Avaliação econômica em saúde: aplicações em doenças infecciosas. Cad. Saúde Pública 25(12), 2543–2552 (2009)CrossRefGoogle Scholar
  29. 29.
    von Campenhausen, S., Winter, Y., Silva, A.R., Sampaio, C., Ruzicka, E., Barone, P., Poewe, W., Guekht, A., Mateus, C., Pfeiffer, K.P., Berger, K., Skoupa, J., Botzel, K., Geiger-Gritsch, S., Siebert, U., Balzer-Geldsetzer, M., Oertel, W.H., Dodel, R., Reese, J.P.: Costs of illness and care in Parkinson’s disease: an evaluation in six countries. Eur. Neuropsychopharmacol. 21, 180–191 (2011)CrossRefGoogle Scholar
  30. 30.
    Watts, J.J., McGinley, J.L., Huxham, F., Menz, H.B., Iansek, R., Murphy, A.T., Waller, E.R., Morris, M.E.: Cost effectiveness of preventing falls and improving mobility in people with Parkinson disesase: protocol for an economic evaluation alongside a clinical trial. BMC Geriatrics 8(23), 1–8 (2008)Google Scholar
  31. 31.
    Weir, S., Samnaliev, M., Kuo, T.C., Tierney, T.S., Autiero, S.W., Taylor, R.S., Schrag, A.: Short- and long-term cost and utilization of health care resources in Parkinson’s disease in the UK. Mov. Disord. 33(6), 974–981 (2018)CrossRefGoogle Scholar
  32. 32.
    Winter, Y., von Campenhausen, S., Brozova, H.: Costs of Parkinson’s disease in Eastern Europe: a Czech cohort study. Parkinsonism and Relat. Disorders 16(1), 51–56 (2010)CrossRefGoogle Scholar
  33. 33.
    Yang, J.X., Chen, L.: Economic burden analysis of Parkinson’s disease patients in China. Hindawi Parkinson’s Disease 1–7 (2017)Google Scholar
  34. 34.
    Yoritaka, A., Fukae, J., Hatano, T., Oda, E., Hattori, N.: The direct cost of Parkinson disease at Juntendo medical university hospital, Japan. Intern. Med. 55(2), 113–119 (2016)CrossRefGoogle Scholar
  35. 35.
    Yu, W., Ravelo, A., Wagner, T.H., Barnett, P.G.: The relationships among age, chronic conditions, and healthcare costs. Am. J. Managed Care 10(12), 909–916 (2004)Google Scholar
  36. 36.
    Zhao, Y.J., Tan, L.C.S., Li, S.C., Au, W.L., Seah, S.H., Lau, P.N., Luo, N., Wee, H.L.: Economic burden of Parkinson’s disease in Singapore. Eur. J. Neurol. 18, 519–526 (2011)Google Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Sávio Luís Oliveira da Silva
    • 1
    Email author
  • Oswaldo Luiz Gonçalves Quelhas
    • 1
  • Julio Vieira Neto
    • 1
  • Marco Antônio Araújo Leite
    • 1
  1. 1.Fluminense Federal UniversityNiteróiBrazil

Personalised recommendations